Brain stimulation trial targets Psychopathy's social blind spots
NCT ID NCT07635940
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether transcranial magnetic stimulation (TMS), a noninvasive brain stimulation technique, can temporarily improve social cognition and brain function in 60 adults with high psychopathic traits. Participants will receive either real or sham TMS over three sessions, with brain scans and social thinking tests before and after. The goal is to see if TMS can safely alter how the brain processes emotions and social cues in this population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial magnetic stimulation (TMS)
What this could lead to
If it works, this could point toward a noninvasive brain stimulation method to improve social cognition in people with psychopathy.
What could go wrong
This is a very early, small study (60 people) testing only single sessions of TMS. It may not produce lasting changes or translate to real-world benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact